KRRO
KRRO
NASDAQ · Biotechnology

Korro Bio Inc

$12.57
+1.03 (+8.93%)
As of Feb 8, 2:10 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 15.81M 16.40M 15.17M
Net Income -3,409,270 -3,544,265 -2,816,245
EPS
Profit Margin -21.6% -21.6% -18.6%
Rev Growth -2.4% +19.8% +8.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 17.01M 18.25M 14.30M
Total Equity 51.94M 49.68M 50.11M
D/E Ratio 0.33 0.37 0.29
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -3,096,571 -3,398,004 -2,964,187
Free Cash Flow -3,396,527 -3,167,900 -2,994,560